For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring a…
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing. That…
Blog
The unseen costs of banning PBM-owned pharmacies in Tennessee
Tennessee lawmakers recently passed the FAIR Rx Act, which would bar companies from owning pharmacies while also operating a pharmacy benefit manager (PBM) and…
Search Posts
News Release
DAILY DIARY: DEBUNK THE JUNK – APRIL 3, 2004
My academic journey has not been easy. Fortunately, I have always been very inquisitive and love reading so that combination has led me…
News Release
DAILY DIARY – Debunk the Junk Report – APRIL 2, 2004
Receipts available as a pdf. “Even when all the experts agree, they may well be mistaken.” – Bertrand…
Products
Q&A with Roger Bate and Richard Tren
Full Document Available in PDF CEI recently interviewed Dr.
Products
Q&A With Paul Driessen
Full Document Available in PDF…
Products
Sympathy for the Mosquito? Anti-Spraying Hysteria Reaches the Absurd
Full Document Available in PDF “Save Our…
News Release
Soso’s receipts
Proof that Soso is adhering to her all McDonald's diet.